Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pan Zheng

Showing results (1-10 of 281) with videos related to

Pageof 29
Sort By:
Mathematical Biosciences and Engineering : MBE|January 19, 2023
On a two-species competitive predator-prey system with density-dependent diffusionPan Zheng
Trends in Pharmacological Sciences|December 15, 2019
Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer ImmunotherapyYang Liu, Pan Zheng
Trends in Immunology|May 29, 2007
CD24: a genetic checkpoint in T cell homeostasis and autoimmune diseasesYang Liu, Pan Zheng
International Journal of Clinical and Experimental Pathology|December 17, 2008
FoxP3: a life beyond regulatory T cellsYang Liu, Pan Zheng
Asian Journal of Pharmaceutical Sciences|March 9, 2022
Calcium ion nanomodulators for mitochondria-targeted multimodal cancer therapyPan Zheng, Jianxun Ding
Cell & Bioscience|May 11, 2018
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?Fei Tang, Pan Zheng
Pharmacogenomics|November 24, 2007
FOXP3 and breast cancer: implications for therapy and diagnosisYang Liu, Pan Zheng
Trends in Immunology|December 1, 2018
How Does an Anti-CTLA-4 Antibody Promote Cancer Immunity?Yang Liu, Pan Zheng
Methods (San Diego, Calif.)|May 14, 2026
Intelligent Methods in Bioinformatics and GenomicsPan Zheng, Xiangxiang Zeng
Frontiers in Immunology|May 25, 2023
CD24-Siglec interactions in inflammatory diseasesYang Liu, Pan Zheng
Pageof 29

Showing results (1-10 of 281) with videos related to

Sort By:
Pageof 29
Mathematical Biosciences and Engineering : MBE|January 19, 2023
On a two-species competitive predator-prey system with density-dependent diffusionPan Zheng
Trends in Pharmacological Sciences|December 15, 2019
Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer ImmunotherapyYang Liu, Pan Zheng
Trends in Immunology|May 29, 2007
CD24: a genetic checkpoint in T cell homeostasis and autoimmune diseasesYang Liu, Pan Zheng
International Journal of Clinical and Experimental Pathology|December 17, 2008
FoxP3: a life beyond regulatory T cellsYang Liu, Pan Zheng
Asian Journal of Pharmaceutical Sciences|March 9, 2022
Calcium ion nanomodulators for mitochondria-targeted multimodal cancer therapyPan Zheng, Jianxun Ding
Cell & Bioscience|May 11, 2018
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?Fei Tang, Pan Zheng
Pharmacogenomics|November 24, 2007
FOXP3 and breast cancer: implications for therapy and diagnosisYang Liu, Pan Zheng
Trends in Immunology|December 1, 2018
How Does an Anti-CTLA-4 Antibody Promote Cancer Immunity?Yang Liu, Pan Zheng
Methods (San Diego, Calif.)|May 14, 2026
Intelligent Methods in Bioinformatics and GenomicsPan Zheng, Xiangxiang Zeng
Frontiers in Immunology|May 25, 2023
CD24-Siglec interactions in inflammatory diseasesYang Liu, Pan Zheng
Pageof 29